-
The only manufacturer of VZIG in the United States recently stopped its production. An alternate product, VariZIG, which is manufactured by a Canadian company and has not been approved for use in the United States by the FDA, can be obtained in the United States, but only through expanded access as an investigational new drug.
-
It is widely accepted that vulnerable patients are best protected from acquiring invasive mold diseases by placing them in a protected environment, supplying sterile air by means of HEPA filtration with or without laminar air flow (LAF). However, there is little to support this contention.
-
TNF Blockers: Should You Be Concerned?; FDA Actions
-
The Ohsaki Study: Does Green Tea Consumption Impact Mortality?; Do Ethnicities Differ in Response to Spironolactone?; MRSA: Once the Exception, Now the Rule; Does Glucose Monitoring Really Help Type 2 Diabetics?; CV Risk in Migraineurs; Motorcycling and Erectile Dysfunction
-
A team from UCSF recently reviewed company documents that were entered into the public record as a result of litigation over the promotion of gabapentin (Neurontin) between 1994 and 1998.
-
For hypertensives with coronary artery disease, lowering the diastolic pressure below 70-80 mm Hg appears to create increased risk of morbidity and mortality from myocardial infarction and all-cause death.
-
The ECG image used in this article was obtained from a previously healthy, middle-aged man with some atypical but new-onset chest discomfort.
-
Other than water, tea is the most often consumed beverage in the world. Animal studies and in vitro data support the potential role of green tea consumption (GTC) for reducing cardiovascular disease and cancer.
-
The FDA has approved the first product for the treatment of Hunter syndrome. Idursulfase is a purified form of iduronate-2-sulfase, a 525-amino acid glycoprotein, produced by recombinant DNA technology.
-
Treatment of Parkinson's disease with dopamine agonist medications may precipitate impulse-control disorders such as compulsive gambling, buying, and hypersexuality.